CCL Life Sciences - Company of the Year - Pharmaceuticals
Company: CCL Life Sciences, Lahore, Pakistan
Company Description: CCL is a multinational pharmaceutical corporation present in more than 22 countries across various regions including South and South East Asia, Central Asia, GCC region, and Africa.
Nomination Category: Company / Organization Categories
Nomination Sub Category: Company of the Year - Pharmaceuticals - Medium-size
Nomination Title: CCL Life Sciences
CCL envisions meeting everyday health, nutrition, home, and personal care needs of a billion people in developing countries. What started as a modest venture with a simple homemade recipe 50 years ago, has now evolved into an international corporation with a footprint across 22 countries in South East Asia, Africa, GCC, and the CIS region. With two manufacturing facilities, located in Pakistan and Vietnam, CCL has constantly been pushing limits and positively impacting the lives of millions of people by providing safe, healthy, and affordable healthcare products.
Shedding light onto the key milestones in our journey, the year 2019 was CCL’s turning point for the better. First and foremost, we revived our operations in Sri Lanka, achieving 150% growth in sales in the year 2019-20 and sustaining market leadership in the diabetic category. In the same year, we also saw a record high growth in revenue of 40% in the Commonwealth Independent States (CIS). Alongside this, September 2020 saw us receiving special import approval in Kazakhstan, enabling us to venture into the largest pharmaceutical market of the CIS region. The rapidly growing business and streamlining operations in both regions came with a strong focus on creating sustainable local employment.
Our vision of making quality healthcare products accessible to the global community, particularly people living in the developing world, pushed us to make our first-ever acquisition in a 5-decade history, and become the first company of Pakistani origin to start operating from the GCC region. We acquired Strat Health Pharma, a UAE-based pharmaceutical company in November 2020. This gave us access to build our brand in the GCC region. Another significant milestone that CCL has achieved over the past year is a Marketing Authorization Letter (MAH) agreement with Pharmevo, a Karachi based pharmaceutical This is a crucial step in establishing CCL as purveyor of innovation, as the MAH is the first-of-its-kind in the pharma industry in the country, wherein CCL will be marketing the products of another Pakistani manufacturer in the Cambodian market.
At CCL, our core purpose is to excel at what we do. It empowers us to keep working towards our goal of enabling healthy and happy lives. Recently, we were awarded by the Federation of Pakistan Chambers of Commerce & Industry (FPCCI), 44th FPCCI Exports Awards for 2019-20 that included the Best Regional Exporter 4 and Special Merit Exporter Award 5. These awards manifest the resilience and dedication of the exceptional and diverse talent housed at CCL.
Reflecting upon the last two years, CCL has indeed come a long way. Not only have we become a leaner organization in terms of employees, we have also adopted contemporary corporate practices with the aim of being an extremely future focused and oriented organization.
The commencement of operations from the UAE has expanded our access to 6 more countries including UAE, Qatar, Bahrain, Saudi Arabia, Lebanon, and Kuwait. Multiple portfolios including women’s health, oncology, and wound management category have become part of CCL’s offerings. Having had numerous first-mover and market leadership positions in various countries previously, we are introducing Rivaroxaban, a preventive medication for blood-clotting, for the Kazakhstani population.
One of the main reasons behind CCL’s growth is its strategic focus on empowerment and development of its people. We, at CCL, value learning that drives us to progress, and helps us keep enabling happy and healthy lives.
Links:
https://www.brecorder.com/news/40033058
https://nation.com.pk/12-Nov-2020/ccl-pharmaceuticals-acquires-uae-based-strathealth-pharma
https://www.thenews.com.pk/print/742417-ccl-acquires-strathealth-pharma
Public announcement: https://www.facebook.com/CCLPharma/posts/262452158763974
Company URL: www.cclpharma.com
Social Media Handles:
https://www.facebook.com/CCLPharma/
https://www.linkedin.com/company/ccl-pharmaceuticals
https://www.instagram.com/cclpharmaceuticals/